The asthma spacers market in North America is expected to grow from US$ 753.08 million in 2022 to US$ 1,035.10 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2022 to 2028.
The rising usage of metered dose inhalers is the major factor driving the growth of the North America asthma spacers market. The extensively increasing prevalence of respiratory conditions, such as asthma and COPD, creates lucrative opportunities to adopt metered-dose inhalers. For instance, according to a study published by a group of researchers at the Department of Pulmonary and Critical Care Medicine, Mayo Clinic, in 2020, the number of asthma cases is expected to reach nearly 52.0% in the next 20 years in the US. Furthermore, according to the same study, the spending for the treatment of asthma in the US is expected to reach US$ 963 billion by 2038, which is expected to drive the uptake of metered-dose inhalers, eventually accelerating the adoption of inhalers and spacers during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America asthma spacers market. The North America asthma spacers market is expected to grow at a good CAGR during the forecast period.
North America Asthma Spacers Market Revenue and Forecast to 2028 (US$ Million)
North America Asthma Spacers Market Segmentation
North America asthma spacers market is segmented into product, distribution channel, and country. Based on product, the Asia Pacific asthma spacers market is segmented into aerochamber, optichamber, volumatic, and inspirease. In 2022, the aerochamber is expected to hold the largest market share and is expected to witness the highest CAGR from 2022 to 2028. Based on distribution channel, the Asia Pacific asthma spacers market is segmented into retail pharmacy, hospital pharmacy, and E-commerce. The retail pharmacy segment is expected to hold the largest share of the market in 2022. Based on country, the North America asthma spacers market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2022.
Agaplastic, Cipla Inc., Koninklijke Philips N.V., Koo Medical Equipment, Laboratoire ProtecSom, Lupin, Metall Zug, Monaghan Medical Corporation, PARI GmbH, and Teleflex Incorporated are among the leading companies in the asthma spacers market in the region.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 753.08 Million |
| Market Size by 2028 | US$ 1,035.10 Million |
| CAGR (2022 - 2028) | 5.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Asthma Spacers Market is valued at US$ 753.08 Million in 2022, it is projected to reach US$ 1,035.10 Million by 2028.
As per our report North America Asthma Spacers Market, the market size is valued at US$ 753.08 Million in 2022, projecting it to reach US$ 1,035.10 Million by 2028. This translates to a CAGR of approximately 5.4% during the forecast period.
The North America Asthma Spacers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Asthma Spacers Market report:
The North America Asthma Spacers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Asthma Spacers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Asthma Spacers Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)